0001415889-23-013116.txt : 20230908
0001415889-23-013116.hdr.sgml : 20230908
20230908160243
ACCESSION NUMBER: 0001415889-23-013116
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230906
FILED AS OF DATE: 20230908
DATE AS OF CHANGE: 20230908
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Young Alethia
CENTRAL INDEX KEY: 0001918147
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35969
FILM NUMBER: 231245277
MAIL ADDRESS:
STREET 1: C/O GRAPHITE BIO, INC.
STREET 2: 201 HASKINS WAY, SUITE 210
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001070081
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043416587
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
BUSINESS PHONE: 9082227000
MAIL ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
FORMER COMPANY:
FORMER CONFORMED NAME: PTC THERAPEUTICS INC
DATE OF NAME CHANGE: 19980909
4
1
form4-09082023_080934.xml
X0508
4
2023-09-06
0001070081
PTC THERAPEUTICS, INC.
PTCT
0001918147
Young Alethia
C/O PTC THERAPEUTICS, INC.
100 CORPORATE COURT
SOUTH PLAINFIELD
NJ
07080
true
false
false
false
0
Common Stock
2023-09-06
4
M
0
7000
27.85
A
16067
D
Common Stock
2023-09-06
4
S
0
7000
39.90
D
9067
D
Common Stock
2023-09-06
4
M
0
4666
27.85
A
13733
D
Common Stock
2023-09-06
4
S
0
4666
39.7926
D
9067
D
Stock Option (Right to Buy)
27.85
2023-09-06
4
M
0
7000
27.85
D
2032-06-08
Common Stock
7000
0
D
Stock Option (Right to Buy)
27.85
2023-09-06
4
M
0
4666
27.85
D
2032-06-08
Common Stock
4666
7334
D
Stock Option (Right to Buy)
39.42
2033-01-04
Common Stock
10000
10000
D
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $39.77 to $39.88 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Currently exercisable.
This option was granted on June 9, 2022 and vests over thirty-six approximately equal monthly installments, commencing on July 8, 2022
This option was granted on January 5, 2023 and vests over one year in twelve equal monthly installments, commencing on February 5, 2023.
/s/ Avraham S. Adler, Attorney-in-Fact
2023-09-08